StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$81.35−4.46 (-5.20%)

Close on Nov 18, 2026Market cap $104.04BP/E 21.6Yield 3.27%

Cvs Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cvs Health's free cash flow for the twelve months ending Jun 30, 2026 was $11.76B, up 146.0% year over year. For fiscal 2025 it was $7.81B, up 23.4% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is $15.75B in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.81B+23.4%
FY2024Dec 31, 2024$6.33B-39.1%
FY2023Dec 31, 2023$10.40B-22.7%
FY2022Dec 31, 2022$13.45B-14.6%
FY2021Dec 31, 2021$15.75B+17.3%
FY2020Dec 31, 2020$13.43B+29.2%
FY2019Dec 31, 2019$10.39B+52.2%
FY2018Dec 31, 2018$6.83B+12.1%
FY2017Dec 31, 2017$6.09B-23.1%
FY2016Dec 31, 2016$7.92B+28.3%
FY2015Dec 31, 2015$6.17B+2.8%
FY2014Dec 31, 2014$6.00B+58.0%
FY2013Dec 31, 2013$3.80B-18.1%
FY2012Dec 31, 2012$4.64B+16.5%
FY2011Dec 31, 2011$3.98B+43.6%
FY2010Dec 31, 2010$2.77B+86.6%
FY2009Dec 31, 2009$1.49B-15.8%
FY2008Dec 31, 2008$1.77B+24.0%
FY2007Dec 29, 2007$1.43B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.65B+338.3%
Q1 FY2026Mar 31, 2026$3.40B-10.8%
Q4 FY2025Dec 31, 2025$2.61B+138.6%
Q3 FY2025Sep 30, 2025$98.00M–
Q2 FY2025Jun 30, 2025$1.29B-47.4%
Q1 FY2025Mar 31, 2025$3.81B-9.2%
Q4 FY2024Dec 31, 2024$1.09B–
Q3 FY2024Sep 30, 2024-$1.42B-165.2%
Q2 FY2024Jun 30, 2024$2.45B-53.9%
Q1 FY2024Mar 31, 2024$4.20B-35.0%
Q4 FY2023Dec 31, 2023-$3.55B–
Q3 FY2023Sep 30, 2023$2.17B-74.6%
Q2 FY2023Jun 30, 2023$5.32B+5.6%
Q1 FY2023Mar 31, 2023$6.45B+156.9%
Q4 FY2022Dec 31, 2022-$2.64B-177.5%
Q3 FY2022Sep 30, 2022$8.54B+73.9%
Q2 FY2022Jun 30, 2022$5.04B-6.1%
Q1 FY2022Mar 31, 2022$2.51B+21.8%
Q4 FY2021Dec 31, 2021$3.41B+19.4%
Q3 FY2021Sep 30, 2021$4.91B+266.6%
Q2 FY2021Jun 30, 2021$5.36B-19.6%
Q1 FY2021Mar 31, 2021$2.06B-19.5%
Q4 FY2020Dec 31, 2020$2.85B+38.1%
Q3 FY2020Sep 30, 2020$1.34B-42.4%
Q2 FY2020Jun 30, 2020$6.67B+40.0%
Q1 FY2020Mar 31, 2020$2.56B+108.0%
Q4 FY2019Dec 31, 2019$2.07B+9.1%
Q3 FY2019Sep 30, 2019$2.33B+317.8%
Q2 FY2019Jun 30, 2019$4.77B+90.3%
Q1 FY2019Mar 31, 2019$1.23B-34.2%
Q4 FY2018Dec 31, 2018$1.89B–
Q3 FY2018Sep 30, 2018$557.00M-73.3%
Q2 FY2018Jun 30, 2018$2.50B+59.7%
Q1 FY2018Mar 31, 2018$1.87B-39.1%
Q4 FY2017Dec 31, 2017-$642.00M-142.7%
Q3 FY2017Sep 30, 2017$2.09B-39.1%
Q2 FY2017Jun 30, 2017$1.57B–
Q1 FY2017Mar 31, 2017$3.08B–
Q4 FY2016Dec 31, 2016$1.50B–
Q3 FY2016Sep 30, 2016$3.43B–

More Cvs Health figures

See a number that looks wrong?